Early research (Phase 1)Study completedNCT00003548What this trial is testingAminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityWho this might be right forCancer NYU Langone Health 20
Early research (Phase 1)WithdrawnNCT00118300What this trial is testingCapecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWho this might be right forCervical CancerEndometrial CancerOvarian Cancer+1 more Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT06867445What this trial is testingMinimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer RecurrenceWho this might be right forCervical CancersVaginal Cancers Fondazione Policlinico Universitario Agostino Gemelli IRCCS 64
Not applicableLooking for participantsNCT05938192What this trial is testingMultimodality Treatments of HPV-related Lesions of the Female Genital TractWho this might be right forHPVCervical CancerCervix Lesion+1 more Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 200
Early research (Phase 1)Ended earlyNCT03277482What this trial is testingDurvalumab, Tremelimumab + Radiotherapy in Gynecologic CancerWho this might be right forRecurrent Gynecological CancerMetastatic Cervical CancerMetastatic Ovarian Cancer+8 more Dana-Farber Cancer Institute 16
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Early research (Phase 1)Study completedNCT00004074What this trial is testingInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/NeuWho this might be right forAdvanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)WithdrawnNCT03220009What this trial is testingNivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal MelanomaWho this might be right forCervical CarcinomaEsophageal CarcinomaMucosal Melanoma+14 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Looking for participantsNCT06677190What this trial is testingBelzutifan in Recurrent Clear Cell Carcinoma of Gynecologic OriginWho this might be right forOvarian CancerOvarian CarcinomaEndometrial Cancer+5 more Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT06023862What this trial is testingA Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)Who this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more Yonsei University 198
Testing effectiveness (Phase 2)Study completedNCT00941070What this trial is testingTriapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal CancerWho this might be right forRecurrent Cervical CancerRecurrent Vaginal CancerStage IB Cervical Cancer+10 more National Cancer Institute (NCI) 26
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Not applicableStudy completedNCT01764789What this trial is testingStress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerWho this might be right forAnxiety DisorderDepressionFatigue+17 more Ohio State University Comprehensive Cancer Center 39
Early research (Phase 1)Study completedNCT00842452What this trial is testingTopotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryWho this might be right forCervical CancerEndometrial CancerFallopian Tube Cancer+4 more Steven Waggoner, MD 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03074513What this trial is testingAtezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsWho this might be right forAppendix AdenocarcinomaHuman Papillomavirus-Related Anal Squamous Cell CarcinomaHuman Papillomavirus-Related Cervical Squamous Cell Carcinoma+18 more M.D. Anderson Cancer Center 133
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00003704What this trial is testingChemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerWho this might be right forCancer Alliance for Clinical Trials in Oncology 51
Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Not applicableStudy completedNCT02786524What this trial is testingEffect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyWho this might be right forUterine Cervical NeoplasmsOvarian NeoplasmsGynecologic Neoplasms+4 more University of Michigan 107
Testing effectiveness (Phase 2)Study completedNCT00002562What this trial is testingPaclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerWho this might be right forCervical CancerVaginal Cancer Gynecologic Oncology Group 25